Highland Instruments, Inc.
10
2
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
100%
4 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Optimization of NIBS for Treatment of Addiction
Role: collaborator
Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability.
Role: collaborator
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Role: collaborator
IMAS Optimization and Applicability in Acute and Subacute Stroke.
Role: collaborator
Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain
Role: collaborator
Effects of tDCS and tUS on Pain Perception in OA of the Knee
Role: collaborator
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
Role: collaborator
Non-invasive Neurostimulation in Parkinson's Disease
Role: collaborator
Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound on Osteoarthritis Pain of the Knee
Role: collaborator
Effects of tDCS and tUS on Pain Perception in OA of the Knee
Role: collaborator
All 10 trials loaded